-The Times of India blog Authoritarian leadership, big corruption, and endless freebies for the masses. These were the hallmarks of Tamil Nadu chief minister Jayalalithaa (popularly called Amma) who died last week. In this week of mourning, she has been praised by even her bitter political foes. Yet this political correctness must not distort her electoral record. Since the 1970s, power in Tamil Nadu has oscillated between the DMK and Amma’s AIADMK....

-The Hindu Business Line Hyderabad: Bayer’s takeover of Monsanto for $66 billion could trigger tremors in Indian agriculture. Stakeholders worry that the global consolidation will narrow choices for farmers. The merger will propel the merged entity into a leading player in the seed sector. Through their subsidiaries and joint ventures in India, the two firms will garner a major share in paddy, maize, vegetables and cotton and agrochemicals. “It will lead to concentration...

-The Hindu In the area of intellectual property, public health and access to medicines, the Narendra Modi government should consider its independence to be of the utmost importance. Strong government leadership as well as flexible intellectual property systems are needed in order to effectively combat drug-resistant tuberculosis (DR-TB) and HIV and also antimicrobial resistance and non-communicable diseases. This is true not only for India but also countries which rely on affordable generic...

-Kafila.org The last few months have seen an unusual public engagement around questions of secularism, freedom of speech, sedition and the like, with furious debates everywhere from our campuses, streets and TV studios to the floor of Parliament. The budget session has been enlivened by scenes of high drama, with the leading lights of the Treasury benches bringing colour, sound and fury to their tutorials on patriotism and nationalism. While these high-decibel...

-TheWire.in The government appears bent on decisively abandoning the earlier consensus of adherence to public health goals. In what is widely being hailed as an extraordinary victory for the multinational pharmaceutical industry over the Indian government, the US-India Business Council (USIBC), in its submission to the United States Trade Representative (USTR), reports that the Indian government has “privately assured” the industry that it would not use compulsory licences (CLs) for commercial purposes....